|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1 to 100 out of 209 for Sars

Category restricted to Publication (x)

<< First    < Previous  |  Next >    Last >>
0.018s

Categories

Category: Publication
Type Details Score
Publication
First Author: Wentworth DE
Year: 2004
Journal: Emerg Infect Dis
Title: Mice susceptible to SARS coronavirus.
Volume: 10
Issue: 7
Pages: 1293-6
Publication  
First Author: Gretebeck LM
Year: 2015
Journal: Curr Opin Virol
Title: Animal models for SARS and MERS coronaviruses.
Volume: 13
Pages: 123-9
Publication      
First Author: Dangi T
Year: 2021
Journal: bioRxiv
Title: SARS coronavirus vaccines protect against different coronaviruses.
Publication
First Author: Tseng CT
Year: 2012
Journal: PLoS One
Title: Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus.
Volume: 7
Issue: 4
Pages: e35421
Publication      
First Author: Mazumder S
Year: 2020
Journal: bioRxiv
Title: PRAK-03202: A triple antigen VLP vaccine candidate against SARS CoV-2.
Publication
First Author: Mann BJ
Year: 2023
Journal: Heliyon
Title: Improved survival of SARS COV-2-infected K18-hACE2 mice treated with adenosine A(2A)R agonist.
Volume: 9
Issue: 8
Pages: e19226
Publication      
First Author: Joyce MGl Chen WH
Year: 2021
Journal: bioRxiv
Title: SARS-CoV-2 ferritin nonoparticle vaccines elicit broad SARS coronavirus immunogenicity.
Publication
First Author: Joyce MG
Year: 2021
Journal: Cell Rep
Title: SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity.
Volume: 37
Issue: 12
Pages: 110143
Publication  
First Author: Chang YS
Year: 2020
Journal: Int J Mol Sci
Title: SARS Unique Domain (SUD) of Severe Acute Respiratory Syndrome Coronavirus Induces NLRP3 Inflammasome-Dependent CXCL10-Mediated Pulmonary Inflammation.
Volume: 21
Issue: 9
Publication
First Author: Huang IC
Year: 2011
Journal: PLoS Pathog
Title: Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus.
Volume: 7
Issue: 1
Pages: e1001258
Publication
First Author: Kuba K
Year: 2005
Journal: Nat Med
Title: A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury.
Volume: 11
Issue: 8
Pages: 875-9
Publication  
First Author: Li SW
Year: 2016
Journal: Sci Rep
Title: SARS coronavirus papain-like protease induces Egr-1-dependent up-regulation of TGF-β1 via ROS/p38 MAPK/STAT3 pathway.
Volume: 6
Pages: 25754
Publication
First Author: Yang XH
Year: 2007
Journal: Comp Med
Title: Mice transgenic for human angiotensin-converting enzyme 2 provide a model for SARS coronavirus infection.
Volume: 57
Issue: 5
Pages: 450-9
Publication  
First Author: Shen ZT
Year: 2016
Journal: Sci Rep
Title: SARS Coronavirus Fusion Peptide-Derived Sequence Suppresses Collagen-Induced Arthritis in DBA/1J Mice.
Volume: 6
Pages: 28672
Publication      
First Author: Sanchez S
Year: 2021
Journal: bioRxiv
Title: Limiting the priming dose of a SARS CoV-2 vaccine improves virus-specific immunity.
Publication
First Author: Yang Y
Year: 2005
Journal: Biochem J
Title: Bcl-xL inhibits T-cell apoptosis induced by expression of SARS coronavirus E protein in the absence of growth factors.
Volume: 392
Issue: Pt 1
Pages: 135-43
Publication
First Author: Chen WH
Year: 2014
Journal: Hum Vaccin Immunother
Title: Yeast-expressed recombinant protein of the receptor-binding domain in SARS-CoV spike protein with deglycosylated forms as a SARS vaccine candidate.
Volume: 10
Issue: 3
Pages: 648-58
Publication      
First Author: Agarwal S
Year: 2022
Journal: bioRxiv
Title: Dietary alphaKG inhibits SARS CoV-2 infection and rescues inflamed lungs to restore normal O2 saturation in animals.
Publication
First Author: McDermott JE
Year: 2016
Journal: BMC Syst Biol
Title: The effect of inhibition of PP1 and TNFα signaling on pathogenesis of SARS coronavirus.
Volume: 10
Issue: 1
Pages: 93
Publication      
First Author: Tscherne A
Year: 2021
Journal: bioRxiv
Title: Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA SARS 2 S in preclinical vaccination.
Publication
First Author: Chang CK
Year: 2006
Journal: J Biomed Sci
Title: Modular organization of SARS coronavirus nucleocapsid protein.
Volume: 13
Issue: 1
Pages: 59-72
Publication      
First Author: Liu R
Year: 2021
Journal: bioRxiv
Title: MVA vector vaccines inhibits SARS CoV-2 replication in upper and lower respiratory tracts of transgenic mice and prevent lethal disease.
Publication      
First Author: Baray JC
Year: 2020
Journal: bioRxiv
Title: BANCOVID, the first D614G variant mRNA-based vaccine candidate against SARS CoV-2 elicits neutralizing antibody and balanced cellular immune response.
Publication      
First Author: Shamseldin MM
Year: 2022
Journal: bioRxiv
Title: Prime-pull immunization of mice with a BcfA-adjuvanted vaccine elicits mucosal immunity and prevents SARS CoV-2 infection and pathology.
Publication
First Author: Law PY
Year: 2006
Journal: FEBS Lett
Title: Expression and functional characterization of the putative protein 8b of the severe acute respiratory syndrome-associated coronavirus.
Volume: 580
Issue: 15
Pages: 3643-8
Publication
First Author: Keng CT
Year: 2006
Journal: Virology
Title: The human severe acute respiratory syndrome coronavirus (SARS-CoV) 8b protein is distinct from its counterpart in animal SARS-CoV and down-regulates the expression of the envelope protein in infected cells.
Volume: 354
Issue: 1
Pages: 132-42
Publication  
First Author: Pereira F
Year: 2020
Journal: Infect Genet Evol
Title: Evolutionary dynamics of the SARS-CoV-2 ORF8 accessory gene.
Volume: 85
Pages: 104525
Publication  
First Author: Mohammad S
Year: 2020
Journal: Pathogens
Title: SARS-CoV-2 ORF8 and SARS-CoV ORF8ab: Genomic Divergence and Functional Convergence.
Volume: 9
Issue: 9
Publication
First Author: Chan JF
Year: 2020
Journal: Lancet
Title: A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster.
Volume: 395
Issue: 10223
Pages: 514-523
Publication  
First Author: Zhang Y
Year: 2021
Journal: Proc Natl Acad Sci U S A
Title: The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-Ι.
Volume: 118
Issue: 23
Publication  
First Author: Geng H
Year: 2021
Journal: Front Immunol
Title: SARS-CoV-2 ORF8 Forms Intracellular Aggregates and Inhibits IFNγ-Induced Antiviral Gene Expression in Human Lung Epithelial Cells.
Volume: 12
Pages: 679482
Publication
First Author: Qiu M
Year: 2005
Journal: Microbes Infect
Title: Antibody responses to individual proteins of SARS coronavirus and their neutralization activities.
Volume: 7
Issue: 5-6
Pages: 882-9
Publication
First Author: Moshynskyy I
Year: 2007
Journal: Virus Res
Title: Intracellular localization of the SARS coronavirus protein 9b: evidence of active export from the nucleus.
Volume: 127
Issue: 1
Pages: 116-21
Publication
First Author: von Grotthuss M
Year: 2003
Journal: Cell
Title: mRNA cap-1 methyltransferase in the SARS genome.
Volume: 113
Issue: 6
Pages: 701-2
Publication
First Author: Meier C
Year: 2006
Journal: Structure
Title: The crystal structure of ORF-9b, a lipid binding protein from the SARS coronavirus.
Volume: 14
Issue: 7
Pages: 1157-65
Publication
First Author: Gralinski LE
Year: 2015
Journal: PLoS Genet
Title: Genome Wide Identification of SARS-CoV Susceptibility Loci Using the Collaborative Cross.
Volume: 11
Issue: 10
Pages: e1005504
Publication
First Author: Liu SJ
Year: 2006
Journal: Vaccine
Title: Immunological characterizations of the nucleocapsid protein based SARS vaccine candidates.
Volume: 24
Issue: 16
Pages: 3100-8
Publication
First Author: Wu F
Year: 2020
Journal: Nature
Title: A new coronavirus associated with human respiratory disease in China.
Volume: 579
Issue: 7798
Pages: 265-269
Publication
First Author: Tan J
Year: 2009
Journal: PLoS Pathog
Title: The SARS-unique domain (SUD) of SARS coronavirus contains two macrodomains that bind G-quadruplexes.
Volume: 5
Issue: 5
Pages: e1000428
Publication
First Author: Imbert I
Year: 2006
Journal: EMBO J
Title: A second, non-canonical RNA-dependent RNA polymerase in SARS coronavirus.
Volume: 25
Issue: 20
Pages: 4933-42
Publication    
First Author: Orduz D
Year: 2015
Journal: Elife
Title: Interneurons and oligodendrocyte progenitors form a structured synaptic network in the developing neocortex.
Volume: 4
Publication
First Author: Luo H
Year: 2005
Journal: Biochemistry
Title: SR-rich motif plays a pivotal role in recombinant SARS coronavirus nucleocapsid protein multimerization.
Volume: 44
Issue: 46
Pages: 15351-8
Publication
First Author: Johnson MA
Year: 2010
Journal: J Mol Biol
Title: SARS coronavirus unique domain: three-domain molecular architecture in solution and RNA binding.
Volume: 400
Issue: 4
Pages: 724-42
Publication
First Author: Lin X
Year: 2021
Journal: iScience
Title: ORF8 contributes to cytokine storm during SARS-CoV-2 infection by activating IL-17 pathway.
Volume: 24
Issue: 4
Pages: 102293
Publication
First Author: Li W
Year: 2003
Journal: Nature
Title: Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus.
Volume: 426
Issue: 6965
Pages: 450-4
Publication
First Author: Wong SK
Year: 2004
Journal: J Biol Chem
Title: A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2.
Volume: 279
Issue: 5
Pages: 3197-201
Publication
First Author: Belouzard S
Year: 2009
Journal: Proc Natl Acad Sci U S A
Title: Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites.
Volume: 106
Issue: 14
Pages: 5871-6
Publication
First Author: Teoh KT
Year: 2010
Journal: Mol Biol Cell
Title: The SARS coronavirus E protein interacts with PALS1 and alters tight junction formation and epithelial morphogenesis.
Volume: 21
Issue: 22
Pages: 3838-52
Publication
First Author: Surya W
Year: 2018
Journal: Biochim Biophys Acta Biomembr
Title: Structural model of the SARS coronavirus E channel in LMPG micelles.
Volume: 1860
Issue: 6
Pages: 1309-1317
Publication
First Author: Ma Y
Year: 2015
Journal: Proc Natl Acad Sci U S A
Title: Structural basis and functional analysis of the SARS coronavirus nsp14-nsp10 complex.
Volume: 112
Issue: 30
Pages: 9436-41
Publication
First Author: Kamitani W
Year: 2009
Journal: Nat Struct Mol Biol
Title: A two-pronged strategy to suppress host protein synthesis by SARS coronavirus Nsp1 protein.
Volume: 16
Issue: 11
Pages: 1134-40
Publication  
First Author: Sakai Y
Year: 2017
Journal: Virology
Title: Two-amino acids change in the nsp4 of SARS coronavirus abolishes viral replication.
Volume: 510
Pages: 165-174
Publication
First Author: Guarino LA
Year: 2005
Journal: J Mol Biol
Title: Mutational analysis of the SARS virus Nsp15 endoribonuclease: identification of residues affecting hexamer formation.
Volume: 353
Issue: 5
Pages: 1106-17
Publication
First Author: Song W
Year: 2018
Journal: PLoS Pathog
Title: Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2.
Volume: 14
Issue: 8
Pages: e1007236
Publication  
First Author: Graham RL
Year: 2006
Journal: Adv Exp Med Biol
Title: The nsp2 proteins of mouse hepatitis virus and SARS coronavirus are dispensable for viral replication.
Volume: 581
Pages: 67-72
Publication
First Author: Bollmann Y
Year: 2023
Journal: Nat Neurosci
Title: Prominent in vivo influence of single interneurons in the developing barrel cortex.
Volume: 26
Issue: 9
Pages: 1555-1565
Publication
First Author: Akerström S
Year: 2007
Journal: Antiviral Res
Title: Inhibition of SARS-CoV replication cycle by small interference RNAs silencing specific SARS proteins, 7a/7b, 3a/3b and S.
Volume: 73
Issue: 3
Pages: 219-27
Publication
First Author: Huang C
Year: 2011
Journal: PLoS Pathog
Title: SARS coronavirus nsp1 protein induces template-dependent endonucleolytic cleavage of mRNAs: viral mRNAs are resistant to nsp1-induced RNA cleavage.
Volume: 7
Issue: 12
Pages: e1002433
Publication
First Author: Minakshi R
Year: 2009
Journal: PLoS One
Title: The SARS Coronavirus 3a protein causes endoplasmic reticulum stress and induces ligand-independent downregulation of the type 1 interferon receptor.
Volume: 4
Issue: 12
Pages: e8342
Publication
First Author: Gralinski LE
Year: 2017
Journal: G3 (Bethesda)
Title: Allelic Variation in the Toll-Like Receptor Adaptor Protein Ticam2 Contributes to SARS-Coronavirus Pathogenesis in Mice.
Volume: 7
Issue: 6
Pages: 1653-1663
Publication
First Author: Marra MA
Year: 2003
Journal: Science
Title: The Genome sequence of the SARS-associated coronavirus.
Volume: 300
Issue: 5624
Pages: 1399-404
Publication
First Author: Hänel K
Year: 2006
Journal: J Biomed Sci
Title: Solution structure of the X4 protein coded by the SARS related coronavirus reveals an immunoglobulin like fold and suggests a binding activity to integrin I domains.
Volume: 13
Issue: 3
Pages: 281-93
Publication
First Author: Xu K
Year: 2009
Journal: Virology
Title: Severe acute respiratory syndrome coronavirus accessory protein 9b is a virion-associated protein.
Volume: 388
Issue: 2
Pages: 279-85
Publication
First Author: Sharma K
Year: 2011
Journal: PLoS One
Title: SARS-CoV 9b protein diffuses into nucleus, undergoes active Crm1 mediated nucleocytoplasmic export and triggers apoptosis when retained in the nucleus.
Volume: 6
Issue: 5
Pages: e19436
Publication
First Author: Hammond RG
Year: 2017
Journal: Protein Sci
Title: SARS-unique fold in the Rousettus bat coronavirus HKU9.
Volume: 26
Issue: 9
Pages: 1726-1737
Publication  
First Author: Deng L
Year: 2018
Journal: Viruses
Title: Suppression of NF-κB Activity: A Viral Immune Evasion Mechanism.
Volume: 10
Issue: 8
Publication
First Author: Zhang L
Year: 2018
Journal: Autophagy
Title: Viral strategies for triggering and manipulating mitophagy.
Volume: 14
Issue: 10
Pages: 1665-1673
Publication
First Author: Shi CS
Year: 2014
Journal: J Immunol
Title: SARS-coronavirus open reading frame-9b suppresses innate immunity by targeting mitochondria and the MAVS/TRAF3/TRAF6 signalosome.
Volume: 193
Issue: 6
Pages: 3080-9
Publication
First Author: Chen Y
Year: 2015
Journal: J Biol Chem
Title: X-ray Structural and Functional Studies of the Three Tandemly Linked Domains of Non-structural Protein 3 (nsp3) from Murine Hepatitis Virus Reveal Conserved Functions.
Volume: 290
Issue: 42
Pages: 25293-306
Publication
First Author: Neuman BW
Year: 2008
Journal: J Virol
Title: Proteomics analysis unravels the functional repertoire of coronavirus nonstructural protein 3.
Volume: 82
Issue: 11
Pages: 5279-94
Publication      
First Author: Mann BJ
Year: 2022
Journal: bioRxiv
Title: Adenosine A2A receptor (A2AR) agonists improve survival in K28-hACE2 mice following SARS-CoV-2 infection.
Publication
First Author: Roberts A
Year: 2005
Journal: J Virol
Title: Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans.
Volume: 79
Issue: 9
Pages: 5833-8
Publication
First Author: Hogan RJ
Year: 2004
Journal: J Virol
Title: Resolution of primary severe acute respiratory syndrome-associated coronavirus infection requires Stat1.
Volume: 78
Issue: 20
Pages: 11416-21
Publication  
First Author: Nakandakari-Higa S
Year: 2022
Journal: Front Immunol
Title: A minimally-edited mouse model for infection with multiple SARS-CoV-2 strains.
Volume: 13
Pages: 1007080
Publication
First Author: Imai Y
Year: 2008
Journal: Cell
Title: Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury.
Volume: 133
Issue: 2
Pages: 235-49
Publication
First Author: Channappanavar R
Year: 2016
Journal: Cell Host Microbe
Title: Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice.
Volume: 19
Issue: 2
Pages: 181-93
Publication  
First Author: Morales-Nebreda L
Year: 2021
Journal: JCI Insight
Title: Aging imparts cell-autonomous dysfunction to regulatory T cells during recovery from influenza pneumonia.
Volume: 6
Issue: 6
Publication
First Author: Zumla A
Year: 2016
Journal: Nat Rev Drug Discov
Title: Coronaviruses - drug discovery and therapeutic options.
Volume: 15
Issue: 5
Pages: 327-47
Publication
First Author: Netland J
Year: 2010
Journal: Virology
Title: Immunization with an attenuated severe acute respiratory syndrome coronavirus deleted in E protein protects against lethal respiratory disease.
Volume: 399
Issue: 1
Pages: 120-128
Publication
First Author: Menachery VD
Year: 2016
Journal: Proc Natl Acad Sci U S A
Title: SARS-like WIV1-CoV poised for human emergence.
Volume: 113
Issue: 11
Pages: 3048-53
Publication    
First Author: Klemm T
Year: 2020
Journal: EMBO J
Title: Mechanism and inhibition of the papain-like protease, PLpro, of SARS-CoV-2.
Pages: e106275
Publication
First Author: Subbarao K
Year: 2004
Journal: J Virol
Title: Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice.
Volume: 78
Issue: 7
Pages: 3572-7
Publication
First Author: Subbarao K
Year: 2006
Journal: Trends Microbiol
Title: Is there an ideal animal model for SARS?
Volume: 14
Issue: 7
Pages: 299-303
Publication
First Author: Day CW
Year: 2009
Journal: Virology
Title: A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo.
Volume: 395
Issue: 2
Pages: 210-22
Publication
First Author: Hou YJ
Year: 2020
Journal: Cell
Title: SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract.
Volume: 182
Issue: 2
Pages: 429-446.e14
Publication    
First Author: Kumar S
Year: 2020
Journal: Virusdisease
Title: Selection of animal models for COVID-19 research.
Pages: 1-6
Publication  
First Author: Pekosz A
Year: 2006
Journal: Adv Exp Med Biol
Title: Structure, expression, and intracellular localization of the SARS-CoV accessory proteins 7a and 7b.
Volume: 581
Pages: 115-20
Publication
First Author: Yuan X
Year: 2006
Journal: Mol Cells
Title: Mitochondrial location of severe acute respiratory syndrome coronavirus 3b protein.
Volume: 21
Issue: 2
Pages: 186-91
Publication  
First Author: Yuan X
Year: 2005
Journal: Virol J
Title: G0/G1 arrest and apoptosis induced by SARS-CoV 3b protein in transfected cells.
Volume: 2
Pages: 66
Publication
First Author: Yuan X
Year: 2005
Journal: Virus Res
Title: Nucleolar localization of non-structural protein 3b, a protein specifically encoded by the severe acute respiratory syndrome coronavirus.
Volume: 114
Issue: 1-2
Pages: 70-9
Publication
First Author: Zhou P
Year: 2012
Journal: J Gen Virol
Title: Bat severe acute respiratory syndrome-like coronavirus ORF3b homologues display different interferon antagonist activities.
Volume: 93
Issue: Pt 2
Pages: 275-281
Publication
First Author: Kopecky-Bromberg SA
Year: 2007
Journal: J Virol
Title: Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists.
Volume: 81
Issue: 2
Pages: 548-57
Publication
First Author: Ratia K
Year: 2014
Journal: PLoS Pathog
Title: Structural Basis for the Ubiquitin-Linkage Specificity and deISGylating activity of SARS-CoV papain-like protease.
Volume: 10
Issue: 5
Pages: e1004113
Publication      
First Author: Schafer A
Year: 2021
Journal: bioRxiv
Title: Common mechanism of SARS-CoV and SARS-CoV-2 pathogenesis across species.
Publication
First Author: Imai Y
Year: 2005
Journal: Nature
Title: Angiotensin-converting enzyme 2 protects from severe acute lung failure.
Volume: 436
Issue: 7047
Pages: 112-6
Publication
First Author: Hashimoto T
Year: 2012
Journal: Nature
Title: ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation.
Volume: 487
Issue: 7408
Pages: 477-81
Publication
First Author: Frieman MB
Year: 2010
Journal: PLoS Pathog
Title: SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism.
Volume: 6
Issue: 4
Pages: e1000849
Publication
First Author: Khanolkar A
Year: 2009
Journal: J Virol
Title: Toll-like receptor 4 deficiency increases disease and mortality after mouse hepatitis virus type 1 infection of susceptible C3H mice.
Volume: 83
Issue: 17
Pages: 8946-56
Publication
First Author: Xu X
Year: 2016
Journal: PLoS One
Title: Cathepsin L Helps to Defend Mice from Infection with Influenza A.
Volume: 11
Issue: 10
Pages: e0164501
Publication
First Author: Utteridge TD
Year: 2002
Journal: Radiat Res
Title: Long-term exposure of E-mu-Pim1 transgenic mice to 898.4 MHz microwaves does not increase lymphoma incidence.
Volume: 158
Issue: 3
Pages: 357-64